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De novo protein sequencing is essential for understanding cellular processes that govern the func-
tion of living organisms and all post-translational events and other sequence modifications that
occur after a protein has been constructed from its corresponding DNA code. By obtaining the or-
der of the amino acids that composes a given protein one can then determine both its secondary and
tertiary structures through structure prediction, which is used to create models for protein aggre-
gation diseases such as Alzheimer’s Disease. Mass spectrometry is the current technique of choice
for de novo sequencing. However, because some amino acids have the same mass the sequence
cannot be completely determined in many cases. Here, we propose a new technique for de novo
protein sequencing that involves translocating a polypeptide through a synthetic nanochannel and
measuring the ionic current of each amino acid through an intersecting perpendicular nanochannel.
To calculate the transverse ionic current blockaded by a given amino acid we use a Monte Carlo
method along with Ramachandran plots to determine the available flow area, modified by the local
density of ions obtained from molecular dynamics and the local flow velocity ratio derived from the
Stokes equation. We find that the distribution of ionic currents for each of the 20 proteinogenic
amino acids encoded by eukaryotic genes is statistically distinct, showing this technique’s potential
for de novo protein sequencing.
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Living organisms depend on proteins to carry out the
genetic code and perform many vital cellular tasks like
metabolism [1]. To understand how a protein works
one must understand its structure. Proteins are spe-
cial because of how versatile they are in binding to other
molecules, and the structure of these binding sites often
indicate the precise use of a protein.
The first step in understanding protein structure is
knowing the sequence of a protein, meaning the order
of the amino acids that compose it. There are 20 amino
acids that are used as building blocks by eukaryotic genes
to make proteins, all of which have the same chain of
atoms as a backbone. What distinguishes each amino
acid is its side chain, which can span from a single hydro-
gen in the case of glycine (GLY) to containing an indole
functional group in the case of tryptophan [1]. For a pro-
tein to function these amino acids fold up into secondary
and tertiary structures that expose features like bind-
ing sites, which can be predicted based on the protein
sequence. Ongoing research attempts to understand pro-
tein aggregation diseases such as Alzheimer’s Disease [2]
by performing simulations of structure formation, which
would not be possible without the knowledge of the com-
ponents of the peptides and proteins involved. In addi-
tion, protein sequences allow the synthesization of other
proteins, which is necessary to compensate for diseases
like Diabetes Type I in which the body does not produce
the necessary peptide hormone insulin [3, 4].
The most common method for de novo protein or pep-
tide sequencing (namely sequencing a protein for the first
time) is mass spectrometry, a technique that involves
fractionating the peptide into many smaller peptides and
then obtaining the mass-to-charge ratio of each new pep-
tide from the mass spectrometer. The problem with this
technique is that fractionation is often carried out with
gel electrophoresis, which is inherently slow [5]. In addi-
tion, fractionation must be repeated many times to ob-
tain small enough peptides so that one can discern the
composite amino acids from just the total mass-to-charge
ratio [6]. Also, de novo sequencing is sometimes impossi-
ble with this technique since some amino acids have the
same mass and charge (e.g., leucine and isoleucine).
Edman degradation is another common method for de
novo protein or peptide sequencing that utilizes repeated
chemical washing and N-terminal cleaving to identify
the sequence of amino acids one at a time [7]. How-
ever, Edman degradation suffers from the same issue
of fractionation as mass spectrometry since devices can
only reliably sequence peptides up to about 30 amino
acids [8]. Nonetheless, the end result of identification via
chromatography of each singled out chemically modified
amino acid is reliable, albeit slow, but does require the
use of many reagents.
The advent of nanopore DNA sequencing [9, 10] has
brought several modern techniques to protein detection:
longitudinal ionic transport [11, 12] and transverse elec-
tronic transport [13]. In the case of ionic transport
through a single nanopore, detection of the protein fold-
ing state is achieved experimentally and modeled with
exclusion volumes by [11]. Of course, protein sequencing
with such a technique is a more difficult task and has not
been achieved as of yet [12]. In fact, longitudinal ionic
transport detects a current blockade which is the con-
volution of several blockade events from different amino
acids [10].
Transverse electronic transport, a technique in which
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FIG. 1. (Color online) A schematic of the transverse ionic transport sequencing method. Two nanochannels intersect: the
vertical or longitudinal channel along z with radius R and the horizontal or transverse channel along y with radius r. The
polypeptide translocates along the longitudinal channel crossing the transverse channel that contains ions, purple K+ and
green Cl−, that flow along the transverse channel due to an electric field, E⊥, in the +y direction. In this case the polypeptide
consists of neurokinin A starting at the C-terminus at the top of the figure attached to one cysteine (CYS) followed by 10
glutamic acids (GLUs), a negatively charged amino acid, where the last GLU makes up the N-terminus (see section Sequencing
Protocol for more on this structure). This negatively charged polypeptide is driven towards −z by an electric field, E‖, in the
+z direction. The dotted lines represent the top and bottom extremities of the intersection of the transverse channel, which
are expanded to the right along with the thick dashed lines representing the area-limiting cross section (outer black line) and
the Monte Carlo radial limit (inner blue line) that lie in the xz-plane. For visibility purposes the polypeptide is enlarged by
a factor of 3 in both of its dimensions from the actual scale that we used in simulations while the ion radius is enlarged by a
factor of 1.5.
amino acids are detected by a pair of electrodes trans-
verse to peptide translocation, has been shown to be suc-
cessful in identifying single amino acids and even in dif-
ferentiating between tyrosine and phosphotyrosine [13], a
post-translational modification. However, only 12 of the
20 amino acids were able to be detected by this technique
with two different electrode gap distances (0.55 nm and
0.7 nm) since the tunneling current is highly dependent
on this gap distance and an amino acid’s ability to enter
the gap. In other words, a single gap cannot be used for
all amino acids.
This brings us to our proposed technique, sequenc-
ing proteins with transverse ionic transport. Like the
two aforementioned techniques, this method is inspired
by a DNA sequencing method [14, 15] and does not re-
quire reagents or fractionation since these devices do not
place a limit on the length of the polypeptide [10], mean-
ing these nanopore techniques have the potential to be
much faster. The structure of this proposed device is
the same as in [14, 15], with a longitudinal nanochannel
for polypeptide translocation and an intersecting trans-
verse nanochannel for ionic transport driven by an elec-
tric field, E⊥, as in Fig. 1. However, the longitudinal
nanochannel must be larger than in [14] to accomodate
the various sizes of the amino acids and instead of 4 DNA
bases we need to distinguish 20 amino acids. Therefore,
the molecular dynamics (MD) simulation method utilized
in [14] is time prohibitive for our purposes so we resort
to a hard sphere model to account for the electrostatic
properties of each amino acid, which requires only one
MD run per amino acid to execute. Afterwards we use
Monte Carlo sampling to calculate ionic current distri-
butions based on external azimuthal rotations (φ′) and
dihedral angle (φ and ψ) distributions, or Ramachandran
plots. We show that the distribution of ionic currents for
each of the 20 proteinogenic amino acids encoded by eu-
karyotic genes is indeed statistically distinct, and propose
a protocol for de novo protein sequencing based on this
technique.
THEORETICAL APPROACH
Let us then consider the configuration of crossed
nanochannels we have in mind. Although not neces-
sary for our conclusions, we assume for simplicity the
3nanochannels to have circular cross sections. We will dis-
cuss the suggested experimental preparation later in the
manuscript, in the section titled Sequencing Protocol.
The polypeptide of interest unfolds inside a nanochan-
nel pulled with a longitudinal force, while it blocks the
ionic current flowing in a transverse channel, as schemat-
ically shown in Fig. 1.
It is well understood that the hydration layers sur-
rounding each amino acid have different binding energies
[16, 17], which certainly affect the ionic transport trans-
verse to each amino acid. In addition, the amino acid
may attract or repel ions due to its solvated charge or
polarity state [18, 19]. In order to understand the aque-
ous environment of each amino acid and determine its
effect on the ionic transport, we run MD simulations for
each amino acid. We consider the system at normal hu-
man body temperature, 310 K, and the solvated system
is large enough to make quantum effects negligible. This
allows us to use classical molecular dynamics and employ
the highly-parallel NAMD2 [20] to run all of our simula-
tions.
The MD setup starts with a single amino acid isolated
from a straight (dihedral angles ψ = φ = 180◦) peptide
chain, as in Fig. 1 with proline (PRO) as an exception,
which is positioned so that the z-axis is the longitudinal
axis. The rest of the MD methods can be found in the
Supporting Information.
The water padding is large enough in this system to
examine proximal radial distribution functions (pRDFs)
from the amino acid’s surface for K+ and Cl− up to the
point where the concentrations level out to the bulk val-
ues. We use the radius from the surface of the amino
acid because the features in the concentration will be
more prominent as opposed to using the radius from the
origin, since the amino acids have irregular shapes. Sim-
ilarly calculated pRDFs on DNA have been shown to be
fairly accurate for reconstructing the surrounding solute
even when combining all surface atoms’ pRDFs into one
[21, 22], as is done in our calculations.
To obtain the pRDFs, we count the number of ions
(for K+ and Cl−) in 0.5 A˚ thick shells starting from the
surface of each amino acid, which is defined by the in-
tersection of the composing atoms’ van der Waals (vdW)
spheres. We then calculate the volume of each shell by
subtracting the inner volume of the intersecting spheres
from the outer volume, using a grid approximation with
0.1 A˚ sides for each volume calculation. With the num-
ber of ions and the volume of the corresponding shell we
calculate the local concentration of K+ and Cl− as a func-
tion of r>, taken to be the perpendicular distance from
the vdW surface to the radial midpoint of the shell, from
the first shell at r> = 0.25 A˚ to the last at r> = 44.75 A˚,
which is below the 4.8 nm upper bound of water padding.
As can be seen in Fig. 2, the concentrations reach a
sufficiently steady bulk value at varying radii, with the
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FIG. 2. (Color online) Plots of ionic concentration against
distance from each amino acid’s vdW surface, r>, for amino
acids GLU, LYS, and MET. K+ is represented by the purple
line and Cl− is represented by the green line.
maximum bulk r> determined to be approximately 15 A˚.
Therefore we can focus on the part of the plots pertain-
ing to r> ≤ 15 A˚ to determine the solvation properties
of each amino acid. As an example of our numerical pro-
cedure, we have chosen to feature the amino acid GLU
in Fig. 2A, which has a negatively charged side chain at
physiological pH (7.4), lysine (LYS) in Fig. 2B, which
has a positively charged side chain at the same pH, and
methionine (MET) in Fig. 2C, whose side chain is hy-
4drophobic at this pH. These three amino acids are of
similar size, which allows us to better compare the ef-
fects of charge states on transverse ionic current. We
can immediately notice that the part of the pRDFs that
we care about is quite different for each featured amino
acid. GLU in Fig. 2A has a higher concentration of K+
due to its negativity while LYS in Fig. 2B has a higher
concentration of Cl− due to its positivity. Then there is
the hydrophobic MET in Fig. 2C, which appropriately
repels both K+ and Cl− without much preference.
In the setting of an external electric field driving trans-
verse ionic flow around an amino acid within a peptide,
the potential barrier that ions must overcome in trans-
port is influenced mostly by the electric potential in the
neighborhood of the area-limiting cross section perpen-
dicular to the ionic flow, imaged in Fig. 1 as the black
thick-dashed line. This is partly due to the short inter-
ference time between the flowing ions and the circum-
vented amino acid. In our theoretical approach, we treat
the equilibrium ionic concentrations as indicators of this
electric potential to develop a hard sphere model with
which we can calculate the distribution of ionic current
for each amino acid. By calculating an effective radius,
reff , that is applied to every atom in the amino acid be-
yond its vdW radius, we can sample many amino acid
orientations using a Monte Carlo approach to determine
all of the ionic current distributions. We theorize that
most of the variation in the transverse ionic transport
will come from the exclusionary effects of the amino acid
with respect to the direction of ionic flow, meaning that
a large pool of orientations must be sampled to obtain
an accurate view of these distributions.
In order to obtain the effective radius for each amino
acid, we start with the definition of the average transverse
ionic current of an ionic species i, K+ or Cl− in our case,
with valency z˜i flowing around an amino acid.
〈Ii〉 = qz˜i
∫ rf
ri
∫ θf
θi
〈g˜iv˜i(r, θ′(rˆ′), φ′(rˆ′))〉rˆ′rdθdr
= C
∫ rf
ri
〈g˜iv˜i〉rˆ′(r)rdr
= C ′
∫ rf
ri
〈g˜iv˜i〉rˆ′(r) A˜(r)
2r
dr
≈ C ′′
∫ rb
0
gi(r>)vi(r>)
A(r>)
2(r> + r◦)
dr>
= C ′′
∫ rb
reff
gi,bvi,b
A(r>)
2(r> + r◦)
dr>
(1)
Here, the identifying transverse ionic current, Ii, through
the aforementioned area-limiting cross section perpendic-
ular to the ionic flow, is averaged over all rotational ori-
entations equally with rˆ′ representing the unit ~r′ vector
of the amino acid while q is the electron charge and C,
C ′, and C ′′ are constants. [θi, θf ] is the window of θ
where the amino acid under study has non-negligible in-
fluence compared to neighboring amino acids. ri is the
radius where g˜i, the local number density as a function
of spherical coordinates, is first nonzero. rf is the radius
where the influence of the amino acid is no longer felt
in the concentration and thus we need not continue the
integral for the purpose of the effective radius, reff , cal-
culation. v˜i is the transverse velocity through the cross
section as a function of standard spherical coordinates
while A˜(r) is the surface area of the sphere of radius r.
In addition, r> is the perpendicular distance from the
vdW surface to the radial midpoint of a shell of thick-
ness dr> and surface area A, r◦ is the average radius from
the origin to the vdW surface, rb is a value of r> where
the pRDF, gi (plotted in Fig. 2), has become sufficiently
steady around the bulk density, gi,b, so as to represent a
shell in the bulk, vi is the flow velocity of the ion species
i as a function of r>, while vi,b is the maximum of vi,
which occurs in the bulk by construction.
The first approximation that we make is that all of the
rotational orientations are uniformly likely, when in real-
ity θ′ is fairly constant due to the stiffness of the peptide
bond and given how small the diameter of the pore is
in comparison to the length. However, when we average
over φ′ we fully explore the number density around the
shell, so averaging over θ′ does not introduce any new
data but adds more weight to the side chain as opposed
to the ends of the backbone. This counteracts the simpli-
fication we make in our MD runs where we use isolated
amino acids and include the number density at the ends
of the backbone, which would normally be expelled by
the nearest neighbor amino acids. Also, the internal dihe-
drals are assumed fixed since they do not fluctuate much
under the imposed longitudinal electric field (see their
implementation in the current distribution calculations).
Lastly, when we change variables from r to r> we have to
approximate r as r> + r◦, which is a minor approxima-
tion when considering that all of the other functions in
the integral have well-defined transformations. We can
now use the following simplified equation to calculate the
effective radius for our hard sphere model for every amino
acid and ion species combination:∫ rb
reff
A(r>)
2(r> + r◦)
dr> =∫ rb
0
gi(r>)
gi,b
vi(r>)
vi,b
A(r>)
2(r> + r◦)
dr>.
(2)
However, this equation requires the ratio of the trans-
verse flow velocity compared to the bulk, and due to the
small length scales we can use the Stokes equation, simi-
lar to [23]. The details of this calculation can be found in
the Supporting Information. From these calculations we
find that rb = (R− r◦)/2 and then from our pRDF plots
(see Fig. 2) we learn that the bulk concentrations start
at approximately rb ≥ 15 A˚. Therefore for our model to
work we have to take R ≥ 30+max{r◦} = 34.16 A˚, where
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FIG. 3. (Color online) The top graph represents area plots
of Cl− around LYS while the bottom graph shows area plots
of K+ around LYS. The straight magenta line is the average
cross-sectional area that the shell of thickness ∆r> = 0.5 A˚
at r>, the distance from the vdW surface of LYS, occupies in
the plane y = 0. The blue line represents the average cross-
sectional area that the ionic solution, with the number of ions
from the shell of thickness ∆r> = 0.5 A˚ at r>, would occupy
in the plane y = 0 if those ions were reorganized to have bulk
concentration, gi,b. The smooth green curve is the blue curve
modulated by the ratio of the velocity with its maximum,
vi/vi,b, which is plotted in the inset of each graph. The area
under the smooth green curve is equal to the shaded gray area
under the straight magenta curve while the dashed vertical
line marks the effective radius for ion species i specifically for
LYS.
the max is over all amino acids, and then in the interest
of minimizing the bulk ionic current we choose R = 35
A˚. We also set the transverse nanochannel radius to the
same value for simplicity.
The insets of Fig. 3 show the results of our calcula-
tions for vi/vi,b; the top graph represents Cl
− around
LYS while the bottom graph shows K+ around LYS. The
other amino acids have similar parabolic forms for vi/vi,b,
but differing rb because of differing r◦. With vi/vi,b cal-
culated for every amino acid we can return to Eq. (2)
to calculate our effective radii for our hard sphere model.
This calculation is shown graphically in Fig. 3, where
the straight magenta line is the argument (including dr>
as ∆r> = 0.5 A˚) of the left-hand side of Eq. (2), which
is the average cross-sectional area that the shell of thick-
ness ∆r> at r> occupies in the plane of interest (y = 0).
The blue line represents the argument of the right hand
side of Eq. (2), again including dr> as ∆r> = 0.5 A˚
without the modulation of the velocity ratio, leaving the
average cross-sectional area that the ionic solution, with
the number of ions from the shell of thickness ∆r> at
r>, would occupy in the plane of interest (y = 0) if those
ions were reorganized to have concentration gi,b. Finally
the smooth green curve is the blue curve modulated by
vi/vi,b. The area under the smooth green curve is equal
to the shaded gray area under the straight magenta curve,
with the dashed vertical line marking not only where the
shaded gray area ends on the left but also the effective
radius for ion species i for the given amino acid. Be-
cause of the influence of the velocity, the fluctuations in
concentration farther from the amino acid have more ef-
fect than closely bound spikes. For example, the Cl−
ion atmosphere located 1 A˚ from the surface of LYS has
less effect on the effective radius compared to the next
spike in concentration further out from the amino acid,
as seen in the green curve. The fact that LYS is pos-
itively charged still shows in the effective radii though,
with the attractive Cl− ions having a 5.38 A˚ addition to
the vdW surface compared to 6.43 A˚ for the repulsive
K+ ions. The rest of the effective radii can be found in
Table S1 of the Supporting Information.
This brings us to our Monte Carlo calculation of the
transverse ionic current around each amino acid. Now
that we have reff for each ion species that we add to the
vdW radius of every atom in our amino acid, we can
compare the available cross-sectional area through the
y = 0 plane and apply the same bulk concentration and
estimated bulk velocity, gb = 1 M and vb, to all amino
acids to obtain the ionic current values. We do not need
to evaluate the available area in the entire cross section
though since we only need to calculate up to the largest
radius determined by reff for all amino acids. Therefore
we use a radius of R/2 from the origin (see Fig. 1 where
we are now limited to r = R) as the circular boundary
for all of the amino acids since this circle encloses all of
the extended amino acid surfaces in any applicable ro-
tational configuration while also being enclosed by the
bulk boundary defined by r> = rb where the velocity
begins to decline from vb. We also approximate [θi, θf ]
as [pi/4, 3pi/4] by comparing the backbone ends’ vdW ra-
dius to half of the distance in z between amino acids (half
of ideally ∼ 3.8 A˚ [24]). In this manner we can ignore
portions of the cross section that would clearly be dom-
inated by neighboring amino acids for the purposes of
understanding each amino acid’s transverse ionic trans-
port signature.
As previously mentioned, the current becomes sensi-
6tive to rotational conformations and dihedral angles in
this portion of the calculation. Therefore, instead of as-
suming uniformity in θ′ and straight dihedral angles like
we did for the effective radius, we fix θ′ to 0 due to the
rigidity of the peptide bond and we use Ramachandran
plots, [25, 26], to sample realistic values for φ and ψ, di-
hedral angles, which encompass the internal degrees of
freedom for a chain of amino acids [26, 27]. That leaves
the azimuthal angle, φ′, which we leave as uniformly dis-
tributed since as a whole the peptide does not have an
azimuthal preference, except if the peptide is very short
in which case the transverse electric field that is only ap-
plied to a few amino acids can affect the entire chain.
We then apply Monte Carlo to a lone amino acid, the
details of which can be found in the Supporting Infor-
mation. The reason we use a lone amino acid, the same
one from our MD simulations, for calculating the ionic
current distributions is that the first step to understand-
ing the viability of this technique is distinguishing each
amino acid separately via transverse ionic current. Since
most of the exclusion due to the amino acid comes from
the region of small z, where the uniqueness of the amino
acid is demonstrated, the exclusion from one amino acid
in a chain can be derived from our single amino acid
distributions. As a result we do not treat the effect of
neighboring PRO, which alters the dihedral angles so as
to straighten the polypeptide chain. However, changing
an amino acid’s dihedrals slightly does not change the
ionic current distributions much since most of the varia-
tion in the current comes from azimuthal rotation of the
amino acid.
Lastly, we must calculate the bulk velocity, vb, that we
will use in the simple equation for the transverse ionic
current, Ii = qz˜igbvb〈Ai〉 and I =
∑
i Ii, where 〈Ai〉
is the average area outside of the effective surface from
Monte Carlo. This calculation can be found in the Sup-
porting Information, resulting in vb = 77.23 m/s.
RESULTS AND DISCUSSION
With a set of ionic currents for each amino acid deter-
mined from Monte Carlo utilizing our hard sphere model,
we histogram each set of currents and use cubic spline in-
terpolation to arrive at Fig. 4. The ionic currents tend
to form multimodal (most often bimodal) distributions
that are best described as a mixture of several normal
distributions. The first and last peaks of each distri-
bution tend to be the highest due to the variation in
φ′. This is because the ionic current as a function of φ′
is roughly sinusoidal with a period of pi and φ′ is uni-
formly distributed, which means the near minimum and
near maximum values of the ionic current are chosen the
most. Also due to the size of the nanochannels, the ionic
current ranges in the tens of nA, which is well within the
range of modern measurement devices that can resolve
pA currents [15, 28]. Beyond that, this ionic current
only represents up to R/2 of the whole cross section. By
using the parabolic vˆ from the bulk region (see the end of
Sequencing Protocol) we calculate the contribution from
the rest of the cross section, r> > rb but still within the
θ limitations, as 69.86 nA after correcting the velocity for
experiment. This value is comparable to the ionic current
values from Fig. 4, meaning the distinctive component
of the ionic current will not be dwarfed by the bulk in an
experimental setting.
Although a fair number of amino acids do not deviate
much from their vdW size identity, namely PRO remain-
ing on the smaller side (large current) and phenylalanine
on the larger side (small current), many more (e.g., ala-
nine) have shifted due to their interaction with the ions.
However, the vdW volume does remain strongly relevant
in the standard deviation of the distributions, where the
larger amino acids (arginine, phenylalanine, tryptophan,
tyrosine) find more variation in ionic current as the di-
hedrals or φ′ are altered.
At a glance there is significant overlap between all of
the distributions, yet the graph seems crowded mostly
because of the sheer amount of plots to compare. We
quantify the distinguishability of the ionic current distri-
butions by calculating the error in selecting the correct
amino acid, X, given M measurements from X. Based
on the maximum likelihood decision rule [29], the error
is defined by
eXm = 1−
1
J
J∑
j=1
 1
19
{Y }∑
Y 6=X
H
(
M∏
m=1
PX(IXm,j)−
M∏
m=1
PY (IXm,j)
) ,
(3)
where J is the total number of realizations of the error
calculation, {Y } is the set of all 20 amino acids, H is the
Heaviside step function, and PY (IXm,j) is the probabil-
ity of IXm,j , the jth realization of the mth ionic current
measurement sampled from the current distribution for
X, in Y ’s ionic current distribution. Here, we assume
that each measurement of ionic current is approximately
independent. Next we average over X to obtain 〈eXm〉X
and then multiply by 100 to get the error percentage,
which is plotted in the inset of Fig. 4. The error drops
at a moderate rate with increasing M , but significantly
drops off for M > 160 when the likelihood of at least one
measurement giving zero probability to incorrect amino
acids becomes very likely, making the product of those
incorrect probabilities zero. For instance, at M = 175
the error percentage is practically 0%, and certainly less
than 0.1%, a reasonable level of error. With a measure-
ment frequency of 100 kHz, [28], and a best case scenario
of 175 measurements per residue without any lapses in
between, the sequencing rate becomes 571 residues per
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FIG. 4. (Color online) The transverse ionic current distributions for all 20 proteinogenic amino acids encoded by eukaryotic
genes (identified with their standard three-letter abbreviations). The distributions have been normalized to the current values
in nA. The inset plots the average error percentage over all 20 amino acids of identifying an amino acid correctly using M
current measurements from that amino acid where the error percentage is on a log scale.
second.
SEQUENCING PROTOCOL
To build a nanofluidic device with intersecting channels
as we suggest one may employ focused ion beam milling,
as achieved in [15] with two 10 nm diameter intersect-
ing nanochannels. Our model requires two 7 nm diame-
ter intersecting nanochannels, which is certainly achiev-
able given that [30] has shown non-intersecting sub-5 nm
nanochannels from the focused ion beam milling tech-
nique. Although we have predicted that all 20 amino
acids are statistically distinct within the framework of
circular channels, other cross sections like rectangles or
ellipses for the transverse channel allow fewer amino acids
to blockade the ionic transport but still provide enough
space for ions to flow past the translocating polypeptide.
This results in improved residue selectivity and there-
fore decreased error as well as reduced post-processing
time for deconvolution of the amino acid signals, which
is necessary if more than one amino acid resides in the
nanochannel intersection. Since the source of the dis-
tinguishability of the amino acids is their structural and
electronic uniqueness we can assume that using a rect-
angular or elliptical transverse cross section with enough
space along x for ionic flow would also result in 20 sta-
tistically distinct amino acids.
Once the sequencing device is built with transverse
electrodes to control ionic flow, the protein or polypep-
tide of choice must be unfolded to translocate it through
the longitudinal nanochannel. By using a high enough
pulling force, around 250 pN [24, 31] that we also ap-
ply to our model, the polypeptide will unfold as well
as translocate through the nanochannel. As opposed to
chemical denaturing, force unfolding results in more con-
fined and reliable Ramachandran plots [24, 31], which
directly translates to more reliable ionic current distri-
butions. After the polypeptide is unfolded the pulling
force can be adjusted according to one’s ionic current
measurement frequency and desired rate of error. For ex-
ample, a desired 0.1% or less of error requires M = 175
and with a sequencing rate of 100 kHz as before, the
maximum pulling speed would be 217 nm/s assuming an
amino acid length of 3.8 A˚. As a result, the maximum
applicable pulling force would be ∼ 180 pN [31].
The next issue is then how this polypeptide is pulled
through the nanochannel. As we have discussed, amino
acids have varied charge states in solution. Therefore, to
utilize an electric field for pulling (see Fig. 1) one has to
attach charges to the polypeptide. These charges must be
attached at the end of the chain so that one does not in-
terfere with the ionic transport signatures of each amino
acid. The best way to achieve this is by using a combina-
tion of solid phase peptide synthesis (SPPS), which excels
at synthesizing smaller peptides [32], and native chemical
ligation (NCL) [33] to attach a sequence of charged amino
acids to the N-terminus of the polypeptide under study.
We choose GLU as our charged amino acid because
of how easily differentiable it is from the other amino
acids (see Fig. 4) and how easy it is to produce. Us-
ing Fmoc, 9-fluorenylmethyloxycarbonyl or the chemical
group that protects the N-terminus from reactions until
desired, SPPS starting with N,N-bis(2-mercaptoethyl)-
amide (BMEA) [34] one creates a sequence of GLU with
a length that will give the polypeptide chain plus GLU se-
quence a large enough charge to pull with an electric field.
Fmoc SPPS is also used to attach a CYS residue to the
N-terminus of the unknown polypeptide with a polyethy-
lene glycol (PEG) support [35]. Then one uses NCL to
8take advantage of the transthioesterification reaction to
form a native amide bond between the N-terminal CYS
residue and the thioester precursor BMEA [34].
Another option is to use optical tweezers [36, 37] to
target a terminal amino acid to pull the whole polypep-
tide. This approach has been utilized for longitudinal
nanopore DNA sequencing [38, 39], resulting in more con-
trol over translocation due to the high tunability of opti-
cal tweezers. Advances in optical tweezers further allow a
single beam to trap multiple targets [40], potentially with
computer-generated holograms [41], which would allow
even more control over the entire polypeptide.
SUMMARY
We have proposed a novel de novo protein sequenc-
ing method in which an unfolded protein confined to
a nanochannel is probed by transverse ionic transport
through an intersecting nanochannel. This method
promises to offer improved discrimination between amino
acids by utilizing the 3-dimensional structure and elec-
tronic properties of each amino acid, as compared to
techniques like mass spectrometry that can only probe
total mass and charge [6]. We developed a hard sphere
model for transverse ionic transport that employs the av-
erage equilibrium ionic concentrations surrounding all 20
amino acids derived from MD and ionic flow ratios de-
termined by the Stokes equation. With this hard sphere
model we were able to calculate distributions of ionic cur-
rent for each amino acid based on Monte Carlo sampling
of internal and external rotational conformations. All 20
amino acids were found to be statistically distinct and a
sequencing error rate per residue of less than 0.1% was
obtained with M = 175 measurements per amino acid,
implying a best case scenario of 571 residues per second
with a measurement frequency of 100 kHz [28].
This approach is certainly experimentally achievable
since 10 nm diameter intersecting nanochannels have
been demonstrated for the purpose of DNA sequenc-
ing [15] and polypeptides can be pulled through the
nanochannel with optical tweezers or by adding charged
residues to the polypeptide terminus and employing an
electric field. Protein sequencing is very important since
DNA sequencing cannot predict post-translational modi-
fications and the ability to identify the sequence of a pro-
tein leads to the ability to understand its structure, which
is the key to understanding many crippling diseases like
Alzheimer’s [2]. We therefore hope our work will moti-
vate the experimental realization of the proposed protein
sequencing protocol.
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SUPPORTING INFORMATION
Molecular Dynamics The amino acid is centered
along the z-axis according to the geometric center in z of
its terminal N and C atoms, while the molecule is cen-
tered in the xy-plane according to the geometric center
in x and y of its terminal N atom and a nearest neigh-
boring amino acid’s terminal N atom. To fix the rotation
angle between amino acids, as a convention, the terminal
N atoms always have y = 0, as is the case in Fig. 1.
Since PRO has more rigid dihedral angles, we need
to center it with the help of two neighboring GLYs,
which have flexible dihedral angles, on each side of a sin-
gle PRO. The nearest neighbor GLYs are configured to
have dihedral angles that compensate for those of PRO
while the farthest neighbor GLYs are configured to be
straight, so that PRO and the two straight GLYs are di-
rected along the longitudinal axis while the two straight
GLYs are aligned in the xy-plane. As a result, we can
center and then isolate PRO by using the usual center-
ing method on the geometric average of the two straight
GLYs, staying consistent with the choice of angles for the
rest of the amino acids.
Once the amino acid is isolated, we solvate the system
into a right hexagonal prism with regular hexagonal xy-
planes having a height of 11 nm and an apothem of 5.9
nm to be used in NAMD2 with periodic boundary condi-
tions in all three dimensions of space. This configuration
gives every atom from every amino acid at least 4.8 nm
of water padding in the unit cell, or in other words at
least 9.6 nm of water between any atom and the closest
atom in any neighboring periodic image. We then passi-
vate and ionize the system to about 1 M of KCl, a typ-
ical biological solute. The size of the ions will certainly
change the average local concentrations near the amino
acid, which may then affect the ionic transport. We uti-
lize the CHARMM22 with CMAP force field [42, 43] for
all of the amino acid, TIP3P water, and ion interactions.
Each amino acid was held fixed throughout the run so
that it would not diffuse around and the surrounding
solution could equilibrate and be analyzed consistently.
After equilibrating at 0 K and progressively ramping up
the temperature to 310 K, the system is allowed to evolve
in an NPT ensemble first for 1 ns followed by an NVT
ensemble for 5 ns, all with 1 fs time steps and 1 ps co-
ordinate recordings. The temperature is held fixed using
a Langevin thermostat with a damping coefficient of 5
ps−1. The first ns of the NVT production run is discarded
as transient, leaving 4 ns of run time, or 4000 coordinate
snapshots, to analyze radial concentration profiles.
Velocity calculation Due to the small length scales of
the intersecting portion of our nanochannel system, we
can use the Stokes equation,
d
dx
(
µ
d
dx
vˆi(x)
)
+ qz˜igˆi(x)E⊥ = 0, (S1)
where µ is the dynamic viscosity of the fluid, E⊥ is the
external electric field applied in the y direction, vˆi is
the transverse velocity through the cross section, gˆi is
the local number density, and ion-ion interactions are ig-
nored. Here the flow velocity is independent of y due to
the fact that the transverse nanochannel length is much
larger than the diameter of the longitudinal nanochan-
nel, 2R, and that 2R is comparable to the diameter of
the transverse nanochannel (as depicted in Fig. 1). In-
dependence from z is similarly due to the longitudinal
nanochannel’s length being much larger than 2R but we
must also choose R to be large enough for ions to dif-
fuse along z after they enter the longitudinal channel at
y = ±R. This will make any variation along z have neg-
ligible impact on the end result of an average vi over all
rotational conformations. In our case we simply use the
dynamic viscosity of water (µ = 7.5 × 10−4 Pa · s), even
though the viscosity of water with ions will vary slightly
[23], and a reasonable value of E⊥ = 5 × 108 N/C taken
from [23]. However, we must transform this equation into
one that depends on r> to obtain vi. Since vi and gi are
averages over all rotational orientations, the problem is
condensed to the region x > 0 and [θi, θf ]. With θi and
θf close enough to pi/2, we can approximate r> as x−x◦,
where x◦ is some constant, since at least for the amino
acid backbone the contour lines of r> resemble those of
x. With these approximations we obtain
d
dr>
(
µ
d
dr>
vi(r>)
)
+ qz˜igi(r>)E⊥ = 0. (S2)
This will give us the rough form of vi/vi,b between the
following boundary conditions:
vi(r> = 0) = 0
vi(r> = r¯> =
R− r◦
2
) ≥ vi(r>).
(S3)
r¯> = (R − r◦)/2 is approximately halfway between the
vdW surface and the longitudinal nanochannel surface
and is also our upper bound on r> as the domain of vi.
To obtain vi for the entire range necessary for Eq. (2),
we require that rb = r¯> = (R − r◦)/2 since r¯> must be
in the bulk as well. From our pRDF plots (see Fig. 2) we
learn that the bulk concentrations start at approximately
r> = 15 A˚, meaning that rb ≥ 15 A˚. Therefore for our
model to work we have to take R ≥ 30+max{r◦} = 34.16
A˚, where the max is over all amino acids, and then in the
interest of minimizing the bulk ionic current we choose
R = 35 A˚.
Monte Carlo The Ramachandran plots that we use in
our Monte Carlo calculations account for a 250 pN lon-
gitudinal force that is applied to the polypeptide chain
(ubiquitin and polyglycine in [25]) to pull it through the
nanochannel. The pulling force acts to limit the phase
space available to the dihedral angle pair (φ, ψ), making
the configurations that are close to straight (ψ = φ =
11
180◦) much more appealing [25]. PRO and GLY have sig-
nificantly different plots from the rest of the amino acids
due to how the side chain of PRO bonds with its own
amine nitrogen, part of the amino acid backbone, leading
to restricted dihedrals while GLY has a hydrogen instead
of a side chain leading to more freedom in the dihedrals.
This way, while the rest of the amino acids are described
by the Ramachandran plot of ubiquitin, which contains
all 20 of the proteinogenic amino acids encoded by eu-
karyotic genes and well represents 18 of them, we describe
PRO with the (φ, ψ) plot from the isolated PRO values
within ubiquitin and GLY with the Ramachandran plot
of the polyglycine analog of ubiquitin [25]. With these
Ramachandran plots we use Monte Carlo sampling to ob-
tain (φ, ψ) pairs that we then implement on a lone amino
acid, where the number of realizations is dependent on
the size of the domain of the Ramachandran plot (1408
realizations for ubiquitin). We also rotate the amino acid
in φ′ ∈ [0, 2pi) by all multiples of pi/12. Then the amino
acid is projected onto the y = 0 plane and using Monte
Carlo (1000 realizations) we calculate the area outside
of the effective surface, called Ai, yet within either pi/2
sector of radius R/2 centered around z = 0, where the
ion i will fit according to its vdW radius.
Maximum velocity Since vb is the maximum velocity
between the amino acid and the longitudinal nanochannel
surface as aforementioned, we can use Eq. (S1) to obtain
the max of vˆ, which is equivalent to vb. In this case we
focus on the velocity within the bulk region, namely from
the midpoint between the amino acid and the channel
surface, x = xmid = (R + r◦)/2, to the channel surface,
x = R. We employ the following boundary conditions,
vˆ(x = R) = 0,
vˆ(x = xmid =
R+ r◦
2
) ≥ vˆ(x),
(S4)
which are very similar to Eq. (S3). By assuming a con-
stant bulk concentration, gb, over this region we quickly
come to a parabolic solution to Eq. (S1) as well as de-
termining vb = qz˜gbE⊥(R − r◦)2/4µ, where z˜i has been
simplified to z˜ since both ion species have the same va-
lency. Then we have vb = 154.47 m/s by choosing a
reasonable r◦ = 4 A˚, a necessity in making vb indepen-
dent of the amino acid under study, which is more likely
in experiment. In fact, the absolute value of the velocity
determined from the Stokes equation is known to differ
from experiment, [23], as opposed to the velocity ratio
that we have utilized thus far. However, these differ-
ences appear to be systematic, [23], and can be solved by
dividing vb in half, resulting in the corrected vb = 77.23
m/s.
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TABLE S1. Effective radii in A˚
Amino reff reff
Acid for Cl− for K+
ALA 8.28 7.68
ARG 3.50 4.49
ASN 5.23 5.55
ASP 6.15 4.69
CYS 7.15 6.85
GLN 4.85 5.28
GLU 8.03 7.44
GLY 6.18 5.75
HIS 6.30 6.08
ILE 5.25 4.78
LEU 5.97 5.74
LYS 5.38 6.43
MET 4.92 4.73
PHE 7.87 7.84
PRO 5.02 4.43
SER 6.85 6.99
THR 4.15 4.57
TRP 6.59 6.74
TYR 6.93 7.29
VAL 5.37 5.27
